124 related articles for article (PubMed ID: 9335444)
1. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy.
Zappa M; Castiglione G; Grazzini G; Falini P; Giorgi D; Paci E; Ciatto S
Int J Cancer; 1997 Oct; 73(2):208-10. PubMed ID: 9335444
[TBL] [Abstract][Full Text] [Related]
2. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
3. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
[TBL] [Abstract][Full Text] [Related]
4. Effect of faecal occult blood testing on colorectal cancer mortality in the surveillance of subjects at moderate risk of colorectal neoplasia: a case-control study.
Lamah M; Norris J; Caffarey SM; Broughton M; Marks CG
Int J Colorectal Dis; 2001 Sep; 16(5):313-7. PubMed ID: 11686530
[TBL] [Abstract][Full Text] [Related]
5. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study.
Saito H; Soma Y; Koeda J; Wada T; Kawaguchi H; Sobue T; Aisawa T; Yoshida Y
Int J Cancer; 1995 May; 61(4):465-9. PubMed ID: 7759151
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer mortality in two areas of Tuscany with different screening exposures.
Costantini AS; Martini A; Puliti D; Ciatto S; Castiglione G; Grazzini G; Zappa M
J Natl Cancer Inst; 2008 Dec; 100(24):1818-21. PubMed ID: 19066268
[TBL] [Abstract][Full Text] [Related]
7. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.
Jørgensen OD; Kronborg O; Fenger C
Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
[TBL] [Abstract][Full Text] [Related]
9. Randomised study of screening for colorectal cancer with faecal-occult-blood test.
Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
Lancet; 1996 Nov; 348(9040):1467-71. PubMed ID: 8942774
[TBL] [Abstract][Full Text] [Related]
10. Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study.
Bertario L; Russo A; Crosignani P; Sala P; Spinelli P; Pizzetti P; Andreola S; Berrino F
Eur J Cancer; 1999 Jun; 35(6):973-7. PubMed ID: 10533481
[TBL] [Abstract][Full Text] [Related]
11. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test.
Saito H; Soma Y; Nakajima M; Koeda J; Kawaguchi H; Kakizaki R; Chiba R; Aisawa T; Munakata A
Oncol Rep; 2000; 7(4):815-9. PubMed ID: 10854550
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.
Castiglione G; Visioli CB; Ciatto S; Grazzini G; Bonanomi AG; Rubeca T; Mantellini P; Zappa M
Br J Cancer; 2007 Jun; 96(11):1750-4. PubMed ID: 17453007
[TBL] [Abstract][Full Text] [Related]
13. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study.
Selby JV; Friedman GD; Quesenberry CP; Weiss NS
Ann Intern Med; 1993 Jan; 118(1):1-6. PubMed ID: 8416152
[TBL] [Abstract][Full Text] [Related]
14. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
Mandel JS; Church TR; Ederer F; Bond JH
J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
[TBL] [Abstract][Full Text] [Related]
16. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
[TBL] [Abstract][Full Text] [Related]
17. Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer.
Libby G; Brewster DH; Steele RJ
Br J Surg; 2014 Nov; 101(12):1607-15. PubMed ID: 25219923
[TBL] [Abstract][Full Text] [Related]
18. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
[TBL] [Abstract][Full Text] [Related]
19. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan: a case-control study.
Hiwatashi N; Morimoto T; Fukao A; Sato H; Sugahara N; Hisamichi S; Toyota T
Jpn J Cancer Res; 1993 Nov; 84(11):1110-2. PubMed ID: 8276715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
